|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
1,220,000,000 |
Market
Cap: |
14.41(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$8.77 - $13.53 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 979 |
Guru Rank Value : 0 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Viatris is a global healthcare company. Co.'s portfolio comprises more than 1,400 approved molecules across a range of key therapeutic areas. Co. has four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Key products sold by the Developed Markets segment include Lyrica®, Lipitor®, Creon®, Influvac®, Wixela Inhub, and the EpiPen® Auto-Injector. Key products within the Greater China segment include Lipitor®, Norvasc®, and Viagra®. Key products within the JANZ segment include AMITIZA®, Lipacreon®, Lyrica®, Norvasc®, and Effexor®. Among Co.'s products sold in the Emerging Markets segment are Lipitor®, Lyrica®, Norvasc®, Celebrex®, and anti-retrovirals.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
323,885 |
346,822 |
346,822 |
376,566 |
Total Sell Value |
$3,944,486 |
$4,172,428 |
$4,172,428 |
$4,507,109 |
Total People Sold |
5 |
5 |
5 |
7 |
Total Sell Transactions |
6 |
9 |
9 |
14 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cuneo Andrew |
See Remarks |
|
2024-02-15 |
4 |
AS |
$12.50 |
$50,000 |
D/D |
(4,000) |
38,795 |
|
-8% |
|
Cuneo Andrew |
See Remarks |
|
2024-01-04 |
4 |
AS |
$11.50 |
$46,000 |
D/D |
(4,000) |
42,795 |
|
2% |
|
Cuneo Andrew |
See Remarks |
|
2023-12-14 |
4 |
AS |
$10.50 |
$42,000 |
D/D |
(4,000) |
46,795 |
|
11% |
|
Ni Xiangyang (sean) |
President, Greater China |
|
2023-11-24 |
4 |
S |
$9.37 |
$139,942 |
D/D |
(14,937) |
64,658 |
|
-25% |
|
Ni Xiangyang (sean) |
President, Greater China |
|
2023-11-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,179 |
79,595 |
|
- |
|
Ni Xiangyang (sean) |
President, Greater China |
|
2023-03-06 |
4 |
S |
$11.08 |
$34,891 |
D/D |
(3,148) |
46,416 |
|
6% |
|
Mauro Anthony |
See Remarks |
|
2023-03-04 |
4 |
D |
$11.13 |
$183,511 |
D/D |
(16,488) |
340,330 |
|
- |
|
Mauro Anthony |
See Remarks |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,917 |
340,903 |
|
- |
|
Parrish Mark W |
Director |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,313 |
102,563 |
|
- |
|
Roman Brian |
Global General Counsel |
|
2023-03-04 |
4 |
D |
$11.13 |
$86,625 |
D/D |
(7,783) |
89,419 |
|
- |
|
Roman Brian |
Global General Counsel |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,774 |
89,690 |
|
- |
|
Malik Rajiv |
President |
|
2023-03-04 |
4 |
D |
$11.13 |
$412,878 |
D/D |
(37,096) |
651,496 |
|
- |
|
Malik Rajiv |
President |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
85,314 |
652,784 |
|
- |
|
Higgins Melina E |
|
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,313 |
83,381 |
|
- |
|
Lyons Dillon Joellen |
Director |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,313 |
59,859 |
|
- |
|
Cornwell W Don |
Director |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,313 |
42,510 |
|
- |
|
Campbell Paul |
See Remarks |
|
2023-03-04 |
4 |
D |
$11.13 |
$90,231 |
D/D |
(8,107) |
106,074 |
|
- |
|
Campbell Paul |
See Remarks |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,515 |
106,356 |
|
- |
|
Mark Richard A |
Director |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,313 |
53,478 |
|
- |
|
Kilts James M |
|
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,313 |
98,590 |
|
- |
|
Coury Robert J |
Executive Chairman |
|
2023-03-04 |
4 |
D |
$11.13 |
$744,352 |
D/D |
(66,878) |
1,174,515 |
|
- |
|
Coury Robert J |
Executive Chairman |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
127,970 |
1,176,836 |
|
- |
|
Goettler Michael |
Chief Executive Officer |
|
2023-03-04 |
4 |
D |
$11.13 |
$525,425 |
D/D |
(47,208) |
321,653 |
|
- |
|
Goettler Michael |
Chief Executive Officer |
|
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
107,827 |
323,292 |
|
- |
|
Cuneo Andrew |
See Remarks |
|
2023-03-04 |
4 |
D |
$11.13 |
$32,188 |
D/D |
(2,892) |
50,795 |
|
- |
|
221 Records found
|
|
Page 3 of 9 |
|
|